Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulatory T cells are associated with the tumor immune microenvironment and immunotherapy response in triple-negative breast cancer
Pengfei Huang, Xinyue Zhou, Minying Zheng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Leveraging Single-Cell Multi-Omics to Decode Tumor Microenvironment Diversity and Therapeutic Resistance
Hussein Sabit, Borros Arneth, Timothy M. Pawlik, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 75-75
Open Access | Times Cited: 3
Targeting lipid metabolism in regulatory T cells for enhancing cancer immunotherapy
Yang Liu, Xingyue Wang, Shu‐Rong Wang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189259-189259
Open Access | Times Cited: 2
Breaking Barriers: The Promise and Challenges of Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer
Sawsan Sudqi Said, Wisam Nabeel Ibrahim
Biomedicines (2024) Vol. 12, Iss. 2, pp. 369-369
Open Access | Times Cited: 8
Exploring the therapeutic potential of regulatory T cell in rheumatoid arthritis: Insights into subsets, markers, and signaling pathways
Q. Y. Su, Huan-Cheng Li, Xiaojing Jiang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116440-116440
Open Access | Times Cited: 6
Cathepsin L promotes oesophageal squamous cell carcinoma development and may be associated with tumour-associated macrophages
Zhenhu Zhang, Jianyu Wang, Yamin Shi, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e29273-e29273
Open Access | Times Cited: 4
Breast cancer stroma and its components: Implication in diagnostic and therapeutic
Riya Sharma, Pankaj Kumar, Vijay Kumar, et al.
Elsevier eBooks (2025), pp. 43-68
Closed Access
Tumor Vascular Normalization by B7-H3 Blockade Augments T Lymphocyte-Mediated Antitumor Immunity
Xin Dai, Boran Cao, Xinnan Liu, et al.
European Journal of Pharmacology (2025), pp. 177334-177334
Closed Access
Divide and Conquer—Targeted Therapy for Triple-Negative Breast Cancer
Milica Nedeljković, Ana Vuletić, Katarina Mirjačić Martinović
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1396-1396
Open Access
Cancer Immunotherapy Based on the Bidirectional Reprogramming of the Tumor Microenvironment by a “Brakes Off/ Step on the Accelerator” Core‐Shell Manganese Phosphate/siPD‐L1 Modulator
Fei Xia, Yuqian Lu, Zipeng Gong, et al.
Exploration (2025)
Open Access
Tumor microenvironment-responsive cascaded nanozyme-based composite hydrogel for multi-modility synergistic therapies in cancer treatment
Pengcheng Hu, Jingyun Sha, Qi Gong, et al.
Chemical Engineering Journal (2025), pp. 160591-160591
Open Access
Role of CD4+ T cells in cancer immunity: a single-cell sequencing exploration of tumor microenvironment
Qi An, Li Duan, Yuanyuan Wang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Cancer-associated fibroblasts promote growth and dissemination of esophageal squamous cell carcinoma cells by secreting WNT family member 5A
Lishuai Yao, Changshuai Zhou, Libao Liu, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access
KAT7-acetylated YBX1 promotes hepatocellular carcinoma proliferation by reprogramming nucleotide metabolism
He Huang, Longfei Ren, Yongqiang Zhou, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Thymidine kinase 1 indicates resistance to immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma
Jiajun Wang, Xianglai Xu, Ying Wang, et al.
Cellular Oncology (2025)
Open Access
Analysis of single-cell and spatial transcriptomics in TNBC cell-cell interactions
Yan Xin, Qiji Ma, Qiang Deng, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Therapeutic potential of isochlorogenic acid A from Taraxacum officinale in improving immune response and enhancing the efficacy of PD-1/PD-L1 blockade in triple-negative breast cancer
Tianyun Wang, Jingwei Sun, Li Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
CXCR2P1 enhances the response of gastric cancer to PD-1 inhibitors through increasing the immune infiltration of tumors
Xinchun Wu, Sen Hou, Yingjiang Ye, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Advancing Breast Cancer Treatment: The Role of Immunotherapy and Cancer Vaccines in Overcoming Therapeutic Challenges
Marco Palma
Vaccines (2025) Vol. 13, Iss. 4, pp. 344-344
Open Access
Development of NR0B2 as a therapeutic target for the re-education of tumor associated myeloid cells
Hashni Epa Vidana Gamage, Samuel T Albright, Amanda Smith, et al.
Cancer Letters (2024) Vol. 597, pp. 217086-217086
Open Access | Times Cited: 3
Effect and mechanisms of shikonin on breast cancer cells in vitro and in vivo
Chuyi Yu, Haoyu Xing, Xiaguo Fu, et al.
BMC Complementary Medicine and Therapies (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Spatial transcriptomics in breast cancer: providing insight into tumor heterogeneity and promoting individualized therapy
Junsha An, Yajie Lu, Yuxi Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Single-cell allelic transcriptomic analysis unravels intratumoral gene expression heterogeneity linked to TNBC pathogenesis
Parichitran Ayyamperumal, Hemant Chandru Naik, Amlan Jyoti Naskar, et al.
(2024)
Closed Access
A bibliometric analysis of drug resistance in immunotherapy for breast cancer: trends, themes, and research focus
Rendong Zhang, Qiongzhi Jiang, Zhemin Zhuang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Pan-cancer analysis reveals that TK1 promotes tumor progression by mediating cell proliferation and Th2 cell polarization
LI Zhe-cheng, Zhaoyi Wu, Xing You, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access
TM4SF4 is a diagnostic biomarker accelerating progression of papillary thyroid cancer via AKT pathway
Lizhi Lin, Jialiang Wen, Tiansheng Xu, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top